M LP1 (Lansoprazole Delayed-Release (Orally Disintegrating) 15 mg)
Pill with imprint M LP1 is Yellow, Round and has been identified as Lansoprazole Delayed-Release (Orally Disintegrating) 15 mg. It is supplied by Mylan Pharmaceuticals Inc.
Lansoprazole is used in the treatment of barrett's esophagus; duodenal ulcer; duodenal ulcer prophylaxis; gerd; erosive esophagitis and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Lansoprazole 15 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for M LP1
Lansoprazole Delayed-Release (Orally Disintegrating)
- Imprint
- M LP1
- Strength
- 15 mg
- Color
- Yellow
- Shape
- Round
- Availability
- Rx and/or OTC
- Drug Class
- Proton pump inhibitors
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC)
- 00378-6981
Related Images for "M LP1"
More about lansoprazole
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (128)
- Patient tips
- Drug images
- Compare alternatives
- Pricing & coupons
- Drug class: proton pump inhibitors
Patient resources
- Drug Information
- Lansoprazole (Advanced Reading)
- Lansoprazole Orally Disintegrating Tablets
- Lansoprazole Delayed-Release Capsules
- Lansoprazole Suspension
- Other brands
- Prevacid, Prevacid OTC, Prevacid SoluTab
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.